20 Dec 2018 17:20
Renalytix AI plc
("RenalytixAI" or the "Company")Β
Β
Director/ PDMR Shareholding
Β
The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 3,168 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 112 pence per share.
Β
Following this purchase, Mr Mills is interested in 9,199,568 Ordinary Shares representing 17.09% of the total voting rights in the Company.
Β
Enquiries:
Β
Renalytix AI plc | www.renalytixai.com | |||
James McCullough, CEO | Via Walbrook PR or Tel: +1 646 397 3970 | |||
Β | Β | |||
N+1 Singer (Nominated Adviser & Broker) | Tel: 020 7496 3000 | |||
Aubrey Powell / James White / George Tzimas (Corporate Finance) | Β | |||
Tom Salvesen / Mia Gardner (Corporate Broking) | Β | |||
Β | Β | |||
Walbrook PR Limited | Tel: 020 7933 8780 or renalytix@walbrookpr.com | |||
Paul McManus / Lianne Cawthorne | Mob: 07980 541 893 / 07584 391 303 | |||
| Β | Β | Β | Β | Β |
Β
Β
Β Β
Β
Β
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Β
1 Β | Details of the person discharging managerial responsibilities / person closely associated Β | ||||
a) Β | Name Β Β | Β Harwood Capital LLP (Harwood) as investment manager to North Atlantic Smaller Companies Investment Trust plc and Oryx | |||
2 Β | Reason for the notification Β | ||||
a) Β | Position/status Β Β | Christopher Mills, non-exec director of the issuer and director of NASCIT and Oryx International Growth Fund Ltd | |||
b) Β | Initial notification /Amendment Β Β | Initial Notification | |||
3 Β | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Β | ||||
a) Β | Name Β Β | Renalytix AI plc | |||
b) Β | LEI Β Β | 213800NTOH3FK3WER551 Β | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted Β Β | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary shares of 0.25 pence each | |||
Β | Β | ||||
Β | Identification code | GB00BYWL4Y04 Β | |||
Β | Β | ||||
b) Β | Nature of the transaction Β Β | Share purchase | |||
c) Β | Price(s) and volume(s) | Β | Β | Β | Β |
Β | Β | Price(s) | Volume(s) | Β | |
Β | Β | 112.00 pence | 3,168 | Β | |
Β | Β | Β | Β | Β | |
d) Β | Aggregated information | Β | |||
Β | Β | ||||
- Aggregated volume | 3,168 | ||||
Β | Β | ||||
- Price | Β£3,548.16 | ||||
Β | Β | ||||
e) Β | Date of the transaction Β | 20 December 2018 | |||
f) Β | Place of the transaction Β | London Stock Exchange | |||
Β
Follow the stocks